Hookipa Pharma Inc. vs Moderna, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Moderna, Inc. is the larger company by market value: $90.1 B against $78 M for Hookipa Pharma Inc., 1156 times as much (market caps of Jan 5, 2024 for Hookipa Pharma Inc. and Oct 30, 2026 for Moderna, Inc.). Hookipa Pharma Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $20 M for Hookipa Pharma Inc.
- Both made a net loss: $44 M for Hookipa Pharma Inc. and $2.8 B for Moderna, Inc.
- Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -225.6% for Hookipa Pharma Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Hookipa Pharma Inc. HOOK | Moderna, Inc. MRNA · #275 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2011 | 2010 |
| Size | ||
| Market cap | $78 M* | $90.1 B |
| Revenue | $20 M | $1.9 B |
| Net income | $-44 M▲ best | $-2.8 B |
| Employees | — | 4,700 |
| Valuation | ||
| Price to sales | — | 35.7× |
| Price to book | — | 10.4× |
| Free cash flow yield | — | -2.3% |
| Profitability | ||
| Gross margin | — | 55.4% |
| Operating margin | — | -158.1% |
| Net margin | — | -145.2% |
| Return on equity | — | -28.9% |
| Growth | ||
| Revenue growth | — | -39.9% |
| Revenue growth, 3 years a year | — | -53.4% |
| Financial strength | ||
| Debt to equity | — | 0.1× |
| Cash | ||
| Free cash flow margin | — | -106.2% |
| Shareholder returns | ||
| Shareholder yield | — | 0.0% |
| Strength scores | ||
| Piotroski F-score | — | 3 of 9 |
| Altman Z-score zone | — | safe |
| Data as of | Market cap Jan 2024 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Hookipa Pharma Inc. or Moderna, Inc.?
Moderna, Inc. is the larger company by market value: $90.1 B against $78 M for Hookipa Pharma Inc., 1156 times as much (market caps of Jan 5, 2024 for Hookipa Pharma Inc. and Oct 30, 2026 for Moderna, Inc.). Hookipa Pharma Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Hookipa Pharma Inc. or Moderna, Inc.?
Moderna, Inc. had more revenue: $1.9 B in the year to December 2025 against $20 M for Hookipa Pharma Inc. Both made a net loss: $44 M for Hookipa Pharma Inc. and $2.8 B for Moderna, Inc.
Which is more profitable, Hookipa Pharma Inc. or Moderna, Inc.?
Moderna, Inc. keeps more of each dollar of sales: a net margin of -145.2% against -225.6% for Hookipa Pharma Inc.
More about Hookipa Pharma Inc.
More about Moderna, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.